<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02215343</url>
  </required_header>
  <id_info>
    <org_study_id>MyNewGut, Task 3.3</org_study_id>
    <secondary_id>Grant Agreement no: 613979</secondary_id>
    <nct_id>NCT02215343</nct_id>
  </id_info>
  <brief_title>Effect of Prebiotic and PUFA on the Gut Microbiota and Metabolic Risk Markers</brief_title>
  <acronym>MyNewGut</acronym>
  <official_title>Effect of Prebiotic Fibre and Polyunsaturated Fatty Acid (PUFA) on the Gut Microbiota and Metabolic Risk Markers in a Metabolically Challenged Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>http://mynewgut.eu/partners</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to investigate in detail how a high-(prebiotic)fibre diet
      and a high-PUFA diet affect the gut microbiota composition in a metabolic challenged
      population, and if the diet-induced modulation of the gut microbiota mediates changes in
      metabolic risk markers.

      Intake of both experimental diets over 4 weeks are expected to induce beneficial changes in
      the gut microbiota composition and to affect markers for insulin sensitivity, lipid
      metabolism and inflammation. The investigators hypothesize that the effect of both
      interventions on the metabolic risk markers will be partly mediated by the diet-induced
      changes in the gut microbiota composition.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in gut microbiota composition</measure>
    <time_frame>Week 0, 4, 8, 12</time_frame>
    <description>Gut microbiota composition will be analyzed by use of fecal samples.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in markers for insulin sensitivity</measure>
    <time_frame>Week 0, 4, 8, 12</time_frame>
    <description>Will be measured by use of fasting blood samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in markers for lipid metabolism</measure>
    <time_frame>Week 0, 4, 8, 12</time_frame>
    <description>Will be measured by use of fasting blood samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in markers for inflammation</measure>
    <time_frame>Week 0, 4, 8, 12</time_frame>
    <description>Will be measured by use of fasting blood samples</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in energy expenditure</measure>
    <time_frame>Week 0, 4, 8, 12</time_frame>
    <description>Resting energy expenditure will be measured by indirect calorimetry in a ventilated hood system</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>High fibre diet (wheat bran extract)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>High PUFA diet (fish oil supplement)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Wheat bran extract</intervention_name>
    <description>Patients will be provided with 15g of wheat bran extract (WBE) (Cargill R&amp;D Centre Europe).</description>
    <arm_group_label>High fibre diet (wheat bran extract)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish oil</intervention_name>
    <description>Patients will be provided with a fish oil supplement (capsules), containing 3-4g of N-3 fatty acids (Axellus A/S, Ishøj, Denmark).</description>
    <arm_group_label>High PUFA diet (fish oil supplement)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI: 25-40 kg/m2

          -  Non-smoking

          -  Indices of the Metabolic Syndrome defined by the International Diabetes Federation
             (IDF 2006):

        Central obesity (waist circumference; men: ≥94 cm and women: ≥80 cm) + any one of the
        following; raised triglyceride level (≥1.7 mmol/L), reduced HDL cholesterol (men: &lt;1.03
        mmol/L, women: &lt;1.29 mmol/L), raised BP (systolic ≥130 mm Hg or diastolic ≥85 mm Hg) or
        raised fasting plasma glucose (≥5.6 mmol/L).

        Exclusion Criteria:

          -  Use of antibiotics

          -  Weight change &gt;3 kg 2 months prior to study start

          -  Intensive physical training/ elite athlete

          -  Medication for dyslipidemia, type 2 diabetes or elevated blood pressure

          -  Dietary supplements with pro/prebiotics, dietary fibre or fish oil supplement

          -  Lactation, pregnancy or planning of pregnancy during the study

          -  Gastro intestinal and liver disorders

          -  Chronic inflammatory disorders

          -  Diagnosed psychiatric disorder including treatment required depression

          -  Surgical treatment of obesity and abdominal surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lesli H Larsen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Nutrition, Exercise and Sports, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Nutrition, Exercise and Sports, University of Copenhagen</name>
      <address>
        <city>Frederiksberg</city>
        <zip>1958</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.mynewgut.eu/</url>
    <description>Project website</description>
  </link>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2014</study_first_submitted>
  <study_first_submitted_qc>August 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2014</study_first_posted>
  <last_update_submitted>February 16, 2016</last_update_submitted>
  <last_update_submitted_qc>February 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Arne Astrup</investigator_full_name>
    <investigator_title>Professor, Dr.Med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

